Breed s Hill Capital LLC Takes Position in CME Group Inc. (NASDAQ:CME)

Breed s Hill Capital LLC bought a new stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 1,062 shares of the financial services provider's stock, valued at approximately $247,000.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in CME. Koshinski Asset Management Inc. lifted its position in shares of CME Group by 3.4% during the 4th quarter. Koshinski Asset Management Inc. now owns 3,474 shares of the financial services provider's stock valued at $807,000 after buying an additional 115 shares in the last quarter. Atomi Financial Group Inc. boosted its stake in CME Group by 34.1% during the 4th quarter. Atomi Financial Group Inc. now owns 3,725 shares of the financial services provider's stock worth $865,000 after purchasing an additional 947 shares during the last quarter. MCF Advisors LLC boosted its stake in CME Group by 25.6% during the 4th quarter. MCF Advisors LLC now owns 358 shares of the financial services provider's stock worth $85,000 after purchasing an additional 73 shares during the last quarter. Beaumont Financial Advisors LLC boosted its stake in CME Group by 9.6% during the 4th quarter. Beaumont Financial Advisors LLC now owns 2,029 shares of the financial services provider's stock worth $471,000 after purchasing an additional 177 shares during the last quarter. Finally, Simon Quick Advisors LLC boosted its stake in CME Group by 28.5% during the 4th quarter. Simon Quick Advisors LLC now owns 1,523 shares of the financial services provider's stock worth $354,000 after purchasing an additional 338 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company's stock.

CME Group Trading Up 0.1%

Shares of CME stock opened at $282.00 on Friday. The company's 50-day moving average price is $267.48 and its 200-day moving average price is $248.56. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. The stock has a market cap of $101.62 billion, a price-to-earnings ratio of 29.16, a PEG ratio of 6.76 and a beta of 0.45. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $286.48.

CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, beating the consensus estimate of $2.61 by $0.19. CME Group had a net margin of 57.52% and a return on equity of 13.62%. The firm had revenue of $1.64 billion for the quarter, compared to analysts' expectations of $1.56 billion. During the same quarter in the previous year, the company posted $2.50 EPS. The company's revenue was up 10.4% compared to the same quarter last year. As a group, equities analysts predict that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th will be given a $1.25 dividend. The ex-dividend date of this dividend is Monday, June 9th. This represents a $5.00 dividend on an annualized basis and a yield of 1.77%. CME Group's payout ratio is currently 50.30%.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on CME shares. Piper Sandler lifted their target price on shares of CME Group from $275.00 to $283.00 and gave the stock an "overweight" rating in a research note on Tuesday, April 8th. JPMorgan Chase & Co. lowered their target price on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating on the stock in a research note on Thursday, April 24th. Morgan Stanley lifted their target price on shares of CME Group from $301.00 to $304.00 and gave the stock an "overweight" rating in a research note on Thursday, April 24th. Bank of America lifted their target price on shares of CME Group from $200.00 to $219.00 and gave the stock an "underperform" rating in a research note on Wednesday, April 2nd. Finally, UBS Group lifted their target price on shares of CME Group from $290.00 to $305.00 and gave the stock a "buy" rating in a research note on Friday, April 25th. Three research analysts have rated the stock with a sell rating, seven have given a hold rating, five have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $256.80.

Insider Buying and Selling at CME Group

In other CME Group news, insider Derek Sammann sold 4,650 shares of the company's stock in a transaction dated Monday, May 5th. The shares were sold at an average price of $280.61, for a total value of $1,304,836.50. Following the transaction, the insider now owns 8,336 shares of the company's stock, valued at $2,339,164.96. This represents a 35.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Phyllis M. Lockett sold 1,060 shares of the company's stock in a transaction dated Monday, May 19th. The shares were sold at an average price of $277.88, for a total transaction of $294,552.80. Following the completion of the transaction, the director now directly owns 3,108 shares in the company, valued at $863,651.04. The trade was a 25.43% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 27,884 shares of company stock valued at $7,389,843 over the last 90 days. 0.30% of the stock is owned by insiders.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.